HC Wainwright & Co. Reiterates Buy Rating on Precision BioSciences, Inc. (DTIL)
Rating Change HC Wainwright & Co. analysts reiterated a Buy rating on Precision BioSciences, Inc. (NASDAQ:DTIL) on August 03, 2026.
Read moreReal-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change HC Wainwright & Co. analysts reiterated a Buy rating on Precision BioSciences, Inc. (NASDAQ:DTIL) on August 03, 2026.
Read moreRating Change Barclays analysts upgraded Texas Capital Bancshares, Inc. (NASDAQ:TCBIO) from Underweight to Equal-Weight on August 03, 2026. Market Context Texas Capital…
Read moreRating Change Baird analysts reiterated a Neutral rating on MSA Safety Incorporated (OTC:MNESP) on August 03, 2026. Market Context MSA Safety Incorporated operates in the…
Read moreRating Change HC Wainwright & Co. analysts reiterated a Neutral rating on Alumis Inc. Common Stock (NASDAQ:ALMS) on August 03, 2026.
Read moreRating Change HC Wainwright & Co. analysts reiterated a Buy rating on Balchem Corporation (NASDAQ:BCPC) on August 03, 2026. Market Context Balchem Corporation operates in the…
Read moreRating Change Barclays analysts reiterated a Overweight rating on Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) on August 03, 2026. Market Context Alnylam Pharmaceuticals, Inc.
Read moreRating Change Wolfe Research analysts downgraded Fair Isaac Corporation (NYSE:FICO) from Outperform to Peer Perform on August 03, 2026. Market Context Fair Isaac Corporation…
Read moreRating Change Barclays analysts reiterated a Underweight rating on NOV Inc. (NYSE:NOV) on July 31, 2026. Market Context NOV Inc.
Read moreRating Change Cantor Fitzgerald analysts reiterated a Overweight rating on Healthcare Realty Trust Incorporated (NYSE:HR) on July 31, 2026. Market Context Healthcare Realty Trust…
Read moreRating Change Morgan Stanley analysts reiterated a Equal-Weight rating on ADT Inc. (NYSE:ADT) on July 31, 2026. Market Context ADT Inc.
Read moreRating Change Canaccord Genuity analysts reiterated a Buy rating on Chime Financial, Inc. Class A Common Stock (NASDAQ:CHYM) on July 31, 2026. Market Context Chime Financial, Inc.
Read moreRating Change B. Riley Securities analysts reiterated a Buy rating on SPX Technologies, Inc. (NYSE:SPXC) on July 31, 2026.
Read moreRating Change Citigroup analysts reiterated a Buy rating on Stanley Black & Decker, Inc. (NYSE:SWK) on July 31, 2026. Market Context Stanley Black & Decker, Inc.
Read moreRating Change Stifel analysts reiterated a Hold rating on Gaming and Leisure Properties, Inc. (NASDAQ:GLPI) on July 31, 2026. Market Context Gaming and Leisure Properties, Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on Builders FirstSource, Inc. (NYSE:BLDR) on July 31, 2026. Market Context Builders FirstSource, Inc.
Read moreRating Change Truist Securities analysts reiterated a Buy rating on Builders FirstSource, Inc. (NYSE:BLDR) on July 31, 2026. Market Context Builders FirstSource, Inc.
Read moreRating Change Wells Fargo analysts reiterated a Equal-Weight rating on Builders FirstSource, Inc. (NYSE:BLDR) on July 31, 2026. Market Context Builders FirstSource, Inc.
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on Builders FirstSource, Inc. (NYSE:BLDR) on July 31, 2026. Market Context Builders FirstSource, Inc.
Read moreRating Change Oppenheimer analysts reiterated a Outperform rating on Builders FirstSource, Inc. (NYSE:BLDR) on July 31, 2026. Market Context Builders FirstSource, Inc.
Read moreRating Change Mizuho analysts reiterated a Neutral rating on DT Midstream, Inc. (NYSE:DTM) on July 31, 2026. Market Context DT Midstream, Inc.
Read more